首页> 外文期刊>Investigative ophthalmology & visual science >Evaluation of the human arrestin gene in patients with retinitis pigmentosa and stationary night blindness.
【24h】

Evaluation of the human arrestin gene in patients with retinitis pigmentosa and stationary night blindness.

机译:色素性视网膜炎和固定性夜盲患者中人类抑制素基因的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To establish the DNA sequence of the coding regions of the human arrestin locus and to determine whether defects in this sequence are present among patients with retinitis pigmentosa (RP) or types of stationary night blindness in addition to Oguchi disease. METHODS: The human genomic locus encoding arrestin was cloned in bacteriophage and P1 vectors. The sequence of the intron DNA flanking each exon was determined from these clones. Single-strand conformation polymorphism analysis and direct genomic sequencing techniques were used to screen 272 unrelated patients, comprising 177 patients with autosomal dominant RP, 85 with recessive RP, and 10 with stationary night blindness. RESULTS: The arrestin gene is divided into 16 exons ranging in size from 10 bp to 194 bp, with the open reading frame spanning exons 2 through 16. The authors identified several discrepancies between the genomic sequence the authors obtained and the previously published cDNA and genomic sequences. In the set of patients with dominant RP, the authors found one of three heterozygous missense changes (Arg84Cys, Thr125Met, and Val378Ile) in each of four unrelated patients; none of these changes cosegregated with disease in the respective families. In the set of patients with recessive RP, the authors found one of two heterozygous missense changes in each of two unrelated patients with recessive RP (Pro364Leu and Arg384Cys). One of the patients was the offspring of a consanguineous marriage; because the Arg384Cys change in him was heterozygous, it is unlikely to have been the cause of his RP. Cosegregation studies could not be performed on the patient with the Pro364Leu change. The authors confirmed the existence of two previously described polymorphisms (Ile76Val and a multiallelic polymorphism at codon 403), and the authors identified several silent polymorphisms and rare sequence variants. No sequence changes, other than polymorphic changes also found in some patients with RP, were identified in the patients with stationary night blindness. CONCLUSIONS: We found no evidence that mutations in arrestin are a cause of RP or stationary night blindness other than Oguchi disease. According to the genomic sequence obtained, a region in exon 8 that has been postulated to represent the site of interaction between arrestin and rhodopsin is 100% conserved between humans and all other mammals studied to date.
机译:目的:建立人类抑制素基因座编码区的DNA序列,并确定该序列是否存在缺陷性色素性视网膜炎(RP)或除Oguchi病以外的固定性夜盲患者中是否存在该缺陷。方法:将编码抑制蛋白的人基因组基因座克隆到噬菌体和P1载体中。从这些克隆确定每个外显子侧翼的内含子DNA的序列。使用单链构象多态性分析和直接基因组测序技术筛选了272例无关患者,包括177例常染色体显性RP,85例隐性RP和10例静止性夜盲患者。结果:restarin基因被分为16个外显子,大小从10 bp到194 bp,开放阅读框跨越第2到16个外显子。作者确定了作者获得的基因组序列与先前发表的cDNA和基因组之间的若干差异。序列。在具有显性RP的患者中,作者发现了四个无关患者中的三个杂合错义变化之一(Arg84Cys,Thr125Met和Val378Ile)。这些变化中没有一个与各自家庭的疾病分离。在一组隐性RP患者中,作者发现了两个无关的隐性RP患者(Pro364Leu和Arg384Cys)中的两个杂合错义变化之一。其中一名患者是近亲结婚的后代。由于他体内的Arg384Cys变化是杂合的,因此不太可能成为他的RP的原因。具有Pro364Leu变更的患者无法进行分类研究。作者确认存在两个先前描述的多态性(Ile76Val和403位密码子的多等位基因多态性),并且作者确定了几种沉默多态性和稀有序列变异。在某些夜盲患者中,除了在某些RP患者中还发现了多态性改变外,没有发现序列改变。结论:我们发现没有证据表明除Oguchi病外,restarin突变是RP或平稳性夜盲的原因。根据获得的基因组序列,假设人类和迄今为止研究的所有其他哺乳动物之间100%保守了外显子8中一个区域,该区域被认为代表了抑制蛋白和视紫红质之间的相互作用位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号